HYDERABAD, India--(BUSINESS WIRE)--Nov. 8, 2005--Dr. Reddy’s Laboratories Limited (NYSE:RDY) announced today that the Company has entered into a definitive agreement to acquire Roche’s API business at the state-of-the-art manufacturing site in Cuernavaca, Mexico, including all employees and business supply contracts. The total investment outlay is about USD 59 million including working capital.